SPRC unit SciSparc advances PTSD-related MDMA-N-acylethanolamines IP
SPRC, via SciSparc and NeuroThera-Clearmind collaboration, advances intellectual property for MDMA-N-acylethanolamines aimed at treating PTSD.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.